Investigation on the use of 3% and 5% retinoic acid in peeling solutions as a drug delivery agent after percutaneous induction of collagen with needles (IPCA®): safety profile and application protocol
Emerson de Andrade Lima1; Mariana de Andrade Lima1; Cláudio Eduardo Cavalcante de Araújo2,3; Yara Maria Maia Nakasawa2,3; Nilma Cintra Leal2,3
DOI: https://doi.org/10.5935/scd1984-8773.201810104